The role of p53 as a target for novel cancer therapies

The p53 tumor suppressor protein is encoded by TP53, the most frequently mutated gene in cancer. A review article published in Nature Reviews Clinical Oncology by Professor Klas G Wiman and colleagues at the Department of Oncology–Pathology describes how p53 could be used as a target for new cancer therapies.

Leave A Comment

Your email address will not be published. Required fields are marked *